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Patient-specific three-dimensional 
explant spheroids derived from human nasal 
airway epithelium: a simple methodological 
approach for ex vivo studies of primary ciliary 
dyskinesia
June Kehlet Marthin1*, Elizabeth Munkebjerg Stevens1, Lars Allan Larsen2, Søren Tvorup Christensen3 
and Kim Gjerum Nielsen1
Abstract 
Background: Three-dimensional explant spheroid formation is an ex vivo technique previously used in studies of 
airway epithelial ion and water transport. Explanted cells and sheets of nasal epithelium form fully differentiated sphe-
roids enclosing a partly fluid-filled lumen with the ciliated apical surface facing the outside and accessible for analysis 
of ciliary function.
Methods: We performed a two-group comparison study of ciliary beat pattern and ciliary beat frequency in sphe-
roids derived from nasal airway epithelium in patients with primary ciliary dyskinesia (PCD) and in healthy controls. 
Nasal ciliary cells and sheets were removed on day 1 by nasal brush biopsy and analyzed with regard to ciliary beat 
pattern—and frequency using high-speed video imaging for standard reference values. Three-dimensional explant 
spheroid formation was initiated in the same individual on the same day by incubation of cells and sheets from a 
separate brush biopsy. Harvested spheroids were analyzed earliest possible and values of spheroid ciliary beat pattern 
and frequency were compared to the corresponding reference values from day 1.
Results: Spheroids formed fast in serum-free culture medium. Formation was successful in 15 out of 18 (82%) sampled 
individuals. Thus, formation was successful in seven healthy controls and eight PCD patients, while unsuccessful in 3 with 
PCD due to infection. Median (range) number of days in culture before harvesting of spheroids was 4 (1–5) in healthy 
versus 2 (1–5) in PCD. Spheroid ciliary beat pattern and frequency were unchanged compared to their corresponding 
day 1 standard reference values. Spheroid ciliary beat frequency discriminated highly significant between healthy con-
trols (9.3 Hz) and PCD patients (2.4 Hz) (P < 0.0001). Survival of spheroids was 16 days in a single healthy person.
Conclusion: Patient-specific three-dimensional explant spheroid formation from a minimal invasive nasal brush 
biopsy is a feasible, fast and valid ex vivo method to assess ciliary function with potential of aiding the diagnosis 
of PCD. In addition, it may be a useful model in the investigation of pathophysiological aspects and drug effects in 
human nasal airway epithelium.
Keywords: Airway epithelial, Cell culture, Cilia, ciliogenesis, Three-dimensional explant spheroids, Primary ciliary 
dyskinesia, Ciliary beat pattern, Ciliary beat frequency, Diagnosis
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Background
Primary ciliary dyskinesia (PCD) is a rare, ciliopathic, 
autosomal recessive or X-linked inherited genetic disor-
der that causes defects in the movement of cilia lining the 
respiratory tract, leading to deficient mucociliary clear-
ance and severe, recurrent or chronic upper and lower 
respiratory infections. Diagnosis of PCD is complicated, 
requiring advanced equipment and a high degree of 
expertise. According to the new ERS task force guideline 
for the diagnosis of PCD, it is recommended to improve 
the diagnostic accuracy of high-speed video analysis 
(HSVA) findings by repeating assessments of ciliary beat 
pattern (CBP) and ciliary beat frequency (CBF) after cell 
culture as part of a step-wise work-up algorithm [1].
The steps include:
Step 1: Measurement of nasal nitric oxide (nNO) and 
performing HSVA of ciliated cells removed from the nose 
or lung and placed under a microscope for analysis of 
CBP and CBF immediately after biopsy.
Step 2: Investigation of ciliary ultrastructural defects by 
transmission electron microscopy (TEM) and repeating 
HSVA after cell culture. Normal TEM does not rule out 
PCD.
Step 3: Genetic testing. There are more than 35 known 
PCD-causing genes. Negative genetic testing does not 
rule out PCD.
Assessment of moving cilia in cultured cells, as means 
to assist PCD diagnosis, has been described as “the cili-
ogenesis principle”. In this procedure, a two-dimensional 
primary culture of ciliated cells is expanded and grown 
on collagen-coated plastic dishes until a confluent mon-
olayer is reached, and during which the cells are dec-
iliated. Following this procedure, re-growth of new cilia 
can be induced, either in suspension [2, 3] or on air liquid 
interface (ALI) [4, 5].
Ciliogenesis requires approximately 3–6  weeks from 
biopsy before new cilia are fully re-grown and ciliary 
movement can be analyzed [6].
By re-testing ciliary function and/or ultrastructure in 
newly differentiated cilia after ciliogenesis, secondary 
ciliary defects are intentionally avoided, which can aid 
either the confirmation or exclusion of the PCD diagnosis 
in cases where the initial investigation has been difficult 
[6–8]. In addition to aid difficult PCD diagnosis, in vitro 
culturing of airway epithelial cells in general serves the 
purpose of investigating a wide range of physiological 
parameters associated with the airway epithelium.
In this study, we present a third model for assessing cil-
iary cells in culture.
Patient-specific three-dimensional explant (3D-E) 
monolayered spheroid formation is a minimal invasive, 
simple and fast ex vivo method to assess ciliated airway 
cells from the nose. Nasal epithelial cells are removed 
by a nasal brush biopsy and placed directly in culture 
medium, in which they spontaneously form 3D-E sphe-
roids without undergoing the processes of ciliogenesis. 
3D-E spheroids are accessible for analysis of ciliary func-
tion within only a few days.
Our method comprises a modified version of the pre-
vious well-described model by Pedersen and colleagues, 
where production of free-floating fluid-filled three-
dimensional airway epithelial spheroids derived from 
protease released epithelium of resected human nasal 
polyps was performed [9–12]. Their spheroids could be 
assessed already a few days after polyp resection and 
have been used for extensive basic research, investigat-
ing water permeability and ion transport in healthy and 
cystic fibrosis airway epithelium [9–12].
We here present a simple and rapid method to produce 
ex vivo 3D-E spheroids that can be used to discriminate 
between PCD patients and healthy controls by differ-
ences in CBP and CBF. Feasibility, validity and success 
rates of the method were included in the study. Part of 
this study has been previously presented as a poster at an 
American Thoracic Society Conference [13].
Methods
Participants
Healthy non-smoking individuals and patients with 
confirmed PCD diagnosis were included after written 
informed consent.
PCD patients recruited for the study
Definite PCD patients were recruited from the National 
Danish PCD cohort in whom cystic fibrosis and immuno-
deficiency had been excluded. PCD diagnosis was based 
on characteristic clinical symptoms in combination with 
at least twice repeated high-speed video-microscopic 
recordings showing abnormal ciliary beat pattern and 
frequency. Additional PCD work-up included evaluation 
by TEM analysis, nasal nitric oxide, immunofluorescence 
(IF) staining and genetic testing for specific PCD muta-
tions. For TEM analysis, at least 100 ciliary cross-sections 
per patient were evaluated for ultrastructural defects. 
Nasal nitric oxide (NO) measurements were performed 
using NIOX® (nitric oxide monitoring system; Aerocrine, 
Solna, Sweden) equipment. Gas was aspirated via a nasal 
olive probe inserted into one nostril by use of passive 
sampling flow rate of 5 mL s−1 (~0.3 L min−1). All PCD 
patients in this study cooperated to nasal NO breath-
hold maneuver. A cut  off value of 175  ppb was used in 
alignment with our previous established reference for 
nasal NO breath-hold sampling [14]. IF staining and 
genetic testing were performed post-hoc in some of the 
PCD patients participating in the current study, as part of 
a general ongoing evaluation of our Danish PCD cohort. 
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These tests were performed at The Research Laboratory 
of Prof. Heymut Omran, University Hospital Muenster, 
Department of General Paediatrics, Muenster, Germany.
Nasal brush biopsy
Nasal ciliary cell sheets were removed by nasal brush 
biopsies from the upper third part of the nose, one biopsy 
from each nostril. One biopsy was used for baseline con-
ventional ciliary function analysis (cCFA) using high-
speed video recordings and one was used for the 3D-E 
spheroid formation.
Conventional ciliary function analysis
Ciliary beat pattern and CBF in 5–10 nasal epithelial 
strips were analyzed at room temperature immediately 
after removal from the nose by use of an interference 
contrast microscope (Leica DMLB; Leitz, Stuttgart, Ger-
many) and by digital frame-by-frame assessment of cili-
ary movement and HSVA. Digital image sampling was 
performed at 200 frames per second. cCFA was used as 
our standard reference method.
3D‑E spheroid formation
3D-E spheroid formation followed upon incubation of 
cells and cell sheets from a simple nasal brush biopsy as 
described for cCFA. The nasal material adherent to the 
brush was released by gently swirling the brush directly 
into a 10-mL Falcon tube containing 37 °C DMEM:HAM-
F12 (1:1) medium, supplemented with a serum substitute 
(1% Ultroser-G, IBF Biotechnics, Savage, MD, USA), 
antibiotics (105 UL−1 of penicillin, 100  mgL−1 of strep-
tomycin) and 2  mM  l-glutamine. The cell material was 
then transferred to 2 wells in a 24-well plate (un-coated) 
and further supplemented with culture medium up to 2/3 
of the well volume to prevent the cells from drying out. 
The well plate was placed in a CO2 incubator (5% CO2, 
37  °C), and during the first 4  h of incubation, the well 
plate was tapped gently every 15 min to prevent attach-
ment of the epithelial cells to the bottom of the wells. The 
culture medium was changed daily for the first 2 days and 
three times a week thereafter by simple sedimentation of 
cell material for 15 min in a test tube.
Once the spheroids had formed, a single spheroid 
would be picked randomly from the well by a pipette 
for analysis. To assess CBP and CBF, the spheroids were 
immobilized, between an object glass and a cover glass, 
leaving the spheroids slightly flattened but with preserved 
ciliary motility, which was easily measured using the 
same video microscope under the same technical condi-
tions as described for cCFA (HSVA). Following CBP and 
CBF analysis, the spheroids were killed. The remaining 
spheroids were left alive in the wells for future analysis by 
changing the medium as described above.
Fluorescence microscopy analysis
Suspended samples of epithelial cells from brush biop-
sies were spread onto cover slides, air dried, and stored 
at −80 °C until use as previously described [15, 16]. Cells 
on defrosted slides were fixed in 4% PFA and subjected to 
differential interference contrast (DIC) microscopy and 
immunocytochemical (ICC) analysis [17] with antibodies 
directed against acetylated α-tubulin (mouse anti Ac-Tub; 
Sigma Aldrich), glutamylated α-tubulin (rabbit anti Glu-
Tub; Sigma Aldrich). For immunohistochemical (IHC) 
analysis, 3D-E spheroids in culture medium were trans-
ferred to Falcon tubes and pelleted at ca. 150×g followed 
by fixation in 4% PFA for 15 min. Fixed spheroids were 
isolated by centrifugation and washed with PBS followed 
by addition of 70% ethanol, dehydration, paraffin embed-
ding and sectioning at a thickness of 5 µm, and sections 
were analyzed by DIC microscopy and IHC as previ-
ously described [18] with Ac-Tub and Glu-Tub antibod-
ies. Cells and sections were incubated in corresponding 
Alexa Flour®-conjugated secondary antibodies (Invitro-
gen) for 45 min at RT, and cell nuclei were labeled with 
DAPI staining. Images were captured on a fully motor-
ized Olympus BX63 upright microscope with a DP72 
color, 12.8 megapixel, 4140 × 3096 resolution camera.
Statistical analysis
Paired t test was used for changes in CBP and CBF 
between cCFA values and 3D-E values for the same 
individual. Unpaired t test was used for two-group com-
parisons of CBP and CBF in 3D-E spheroids from PCD 
patients versus healthy controls.
Results
We included 18 individuals in this proof-of-concept 
method study: 11 PCD patients and 7 healthy controls. 
Following nasal brush biopsy, the isolation of epithe-
lial cells was initially confirmed by ICC analysis, show-
ing individual cells ciliated at the apical membrane as 
judged by DIC and staining with cilia-specific antibodies 
(Fig. 1a). 3D-E spheroids formed easily and quickly from 
nasal brush biopsy material when incubated in Ultroser 
G-supplemented culture medium, and spheroid forma-
tion occurred equally quickly in both PCD patients and 
healthy controls. Ready-for-analysis 3D-E spheroids were 
obtained with median (range) number of 2 (1–5) days 
for PCD patients, and 4 (1–5) days for healthy controls 
(Fig. 1b). Sections of fixed 3D-E spheroids from a healthy 
donor were further analyzed by IHC analysis, displaying 
well-organized arrangements of monolayer cells enclos-
ing a partly fluid-filled lumen, with the ciliated apical 
surface facing the outside (Fig. 1c, upper panels). In some 
cases, the fluid-filled lumen was undetectable due to sec-
tioning outside this lumen (Fig. 1c, lower panels). In all 
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experiments, the 3D-E spheroids were often interspersed 
with single cells and other cell materials as a consequence 
of fixation and centrifugation of the cultures prior to par-
affin embedding.
We found a highly consistent and significant difference 
in mean CBF values between 3D-E spheroids derived 
from healthy controls (9.2 Hz) and PCD patients (2.6 Hz) 
(P < 0.0001) (Fig. 2). Hence, our 3D-E spheroids appeared 
equally discriminative between PCD and health as com-
pared to the initial gold standard cCFA. We observed 
no differences in CBP and CBF between spheroid and 
baseline cCFA analyses, neither in healthy controls nor 
PCD patients. For PCD patients, CBP was consistent 
when comparing initial cCFA and 3D-E spheroids, both 
for immotile and dysmotile variants of PCD. CBF seemed 
not to slow down within the tested window of 5  days, 
suggesting that spheroids after 5 days in culture still had 
vital and well-functioning cilia (Table 1).
Healthy spheroids presented themselves in two differ-
ent ways: either as rotating spheroids, where the ciliary 
movements made the spheroid spin around its own axis, 
or as spheroids with beating cilia without rotation.
Fig. 1 Immunofluorescence microscopy analysis of 3D-E spheroids. a Immunocytochemical (ICC) analysis of a ciliated epithelial cell isolated from 
the nasal brush biopsy. Cilia (arrows) are visualized with differential interference contrast (DIC) and with antibodies directed against acetylated 
α-tubulin (Ac-Tub; red) and glutamylated α-tubulin (Glu-Tub; green). The nucleus is stained with DAPI (blue) and the circumference of the cell is 
marked with a dotted line. b DIC microscopy of a live 3D-E spheroid. Cilia are marked with arrows (inset). c Immunohistochemical (IHC) analysis of 
two 3D-E spheroids (#1 and #2) with DIC and with antibodies and staining reagents as indicated for a. Cilia are marked with arrows and the circum-
ferences of the spheroids are marked with dotted lines. fl partly fluid-filled lumen
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The rotating spheroids usually were quite large, con-
taining many cells and usually surrounded by mucus, 
whereas healthy non-rotating spheroids were smaller. 
Examples of healthy rotating, healthy non-rotating and 
PCD spheroids are given in Additional files 1, 2 and 3.
The overall success rate of spheroid formation was 82% 
(15/18). Three samples (all from PCD patients) were lost 
due to infection [success rate healthy controls  =  100%, 
PCD patients = 73% (8/11)]. The yield of spheroids was 
quite variable, ranging from a few (2–3) up to approxi-
mately 20 spheroids per sample. We did not test maximal 
survival time of the spheroids in this study. However, one 
sample of beating spheroids was kept for 16  days, after 
which the spheroids were terminated.
Discussion
In this study, we presented a simple and fast method to 
produce ex  vivo 3D-E ciliated spheroids derived from 
nasal airway epithelium. These spheroids are spontane-
ously formed from terminally differentiated ciliated cells 
presenting their original cilia. This in sharp contrast to 
ciliated organoids derived from the ciliogenesis princi-
ple, which requires multiple steps of cell culturing involv-
ing cell multiplication, differentiation and re-growth of 
the cilia. The spheroids were further allowed to stay in 
Fig. 2 Patient-specific 3D-E spheroid ciliary beat frequency (CBF) 
measured in beat per second (Hz) in-patients with primary ciliary 
dyskinesia (PCD) and healthy controls
Table 1 Comparison of ciliary beat pattern (CBP) and ciliary beat frequency (CBF) in eight patients with primary ciliary 
dyskinesia (PCD) and seven healthy non‑smoking controls measured by conventional ciliary function analysis (cCFA) per‑
formed immediately after brush biopsy and after patient‑specific 3D‑explant spheroid (3D‑E) formation
Healthy Mean CBF, 
cCFA (Hz)
Mean CBF, 
3D-E (Hz)
CBP, cCFA CBP, 3D-E No. of days 
in culture
EM defects IF defects PCD muta-
tion
nNO 
(ppb)
1 10.7 10.0 Synchronous Synchronous 4 – – – –
2 10.0 9.8 Synchronous Synchronous 5 – – – –
3 10.0 11.5 Synchronous Synchronous 4 – – – –
4 8.8 9.0 Synchronous Synchronous 5 – – – –
5 8.3 8.0 Synchronous Synchronous 1 – – – –
6 7.8 9.0 Synchronous Synchronous 3 – – – –
7 5.3 7.0 Synchronous Synchronous 3 – – – –
PCD
 1 0 0 Immotile Immotile 5 ODA DNAH5 (poly-
clonal) abnormal
Awaiting 
results
36
 2 0 0 Immotile/stiff 
flickery
Immotile/stiff 
flickery
2 Radial spoke 
head defect 
+IDA defect
GAS8/11 abnormal 
and DNALI1 
(monoclonal) 
inconclusive
CCDC40 52
 3 0 0 Immotile Immotile 1 ODA DNAH5 (poly-
clonal) inconclu-
sive and DNALI1 
(LC28,polyclonal) 
abnormal
Awaiting 
results
30
 4 3.0 4.0 Asynchronous Asynchronous 2 ODA DNAH5 (poly-
clonal) abnormal
Awaiting 
results
283
 5 3.6 5.0 Asynchronous Asynchronous 2 ODA DNAH5 (poly-
clonal) abnormal
Awaiting 
results
102
 6 5.3 5.0 Asynchronous Asynchronous 5 Normal None found Unknown 101
 7 3.6 5.0 Asynchronous Asynchronous 2 Inconclusive None found Unknown –
 8 3.0 2.0 Stiff and asyn-
chronous
Stiff and asyn-
chronous
2 Sample poor, 
not repeated
Not done Unknown 36
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the culture medium together with the mucus that came 
along with the brush biopsy, thereby partly mimicking 
the in vivo situation. No enzymatic splitting or spinning 
of the cells was performed and the rapid way of forming 
spheroids allowed them ready for ciliary function testing 
after only 1–5  days after brush biopsy, as compared to 
otherwise 3–6 weeks by, e.g. the ALI method [6].
Table 2 sums up the main characteristics and potentials 
of the three methods: (1) ciliogenesis from suspension, 
(2) ciliogenesis from ALI and (3) 3D-E spheroids.
Compared to previous described primary cell cul-
ture techniques for investigating airway ciliated cells, 
we found 3D-E spheroid formation to be advantageous 
and promising in a number of ways that may make the 
method a useful alternative to other primary ciliary cell 
culture methods:
  • Ready-to-test spheroids were produced in only a few 
days after brush biopsy.
  • The sampling technique was minimally invasive. By a 
simple and quite gentle brush biopsy technique, we 
were able to produce free-floating partly fluid-filled 
3D-E spheroids in suspension. The brush biopsy did 
not require analgesics. Due to the minimal pain by a 
brush biopsy, repeated sampling could be offered a 
patient anytime needed.
  • Few laboratory resources are needed. The yield of 
cells from a plain brush biopsy was sufficient to pro-
duce spheroids. No enzymatic splitting or washing 
steps were involved, and hence no cell loss due to 
such procedures.
  • We found the 3D-E spheroids to be highly discrimi-
native between PCD and healthy controls: the 3D-E 
spheroids separated equally well between PCD and 
healthy controls as compared to the initial cCFA, 
both by CBF and CBP.
  • The validity of 3D-E spheroid CBP and CBF was high 
in both PCD and healthy controls, as CBP and CBF 
Table 2 Characteristics and potentials of three airway epithelial culture methods
Ciliogenesis from suspension, ciliogenesis from air–liquid interface (ALI) and 3D-E spheroids
Crude immediate 
brush material [21]
2-step ALI [5, 8, 22, 23] 2-step suspension [2, 3, 
24, 25]
3D-E spheroids [9, 13]
Characteristics
 Sampling of cells Nasal brush biopsy Nasal brush biopsy Removal of nasal polyp or 
nasal forceps biopsy
Removal of nasal polyp/nasal 
brush biopsy
 Anesthesia required No No Yes Yes (polyp removal)
No (nasal brush)
 Preparation steps Cell collection
Cell dispersion
Cell collection
Cell dispersion
Cell proliferation Ciliary 
regeneration
Tissue washing
Enzymatic tissue digestion
Cell dispersion
Cell proliferation
Ciliary regeneration
Cell collection
Cell dispersion
Spheroid formation
 Longevity of cells/culture 1–3 days >1 month >1 month At least 16 days
 Time from sampling to analysis Immediately 4 weeks 4–6 weeks 24 h
 Materials and reagents Falcon tube
NaCl
Glass slide
Falcon tube
Culture medium
T25/75 flask
24-well plate
Transwell insert filters
D-PBS
Trypsin–EDTA
Trypsin-inhibitor
Centrifuge
CO2 incubator
Falcon tube
Pronase
Culture medium
Plastic plate
Collagen gel
Collagenase
T25/75 flask
Gyrotori shaker
CO2 incubator
Falcon tube
Culture medium
24-well plate
CO2 incubator
 Complexity Simple Complex Complex Simple
 Terminally differentiated cells Yes No No Yes
 Cell divisions No Yes Yes No
 Ciliogenesis No Yes Yes No
Known applications
 Diagnostics Yes Yes Yes Yes
 Study of transport mechanisms No Yes No Yes
 Study of ciliary physiology Yes Yes Yes Yes
Potential applications
 Study of drug effects No Yes Yes Yes
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values did not differ significantly from their paired 
initial values found by our standard reference method 
(cCFA).
  • The success rate was high. We had an overall suc-
cess rate of 82%, which is superior to those previously 
described from other in vitro methods (54–79%) [6, 
19].
The spheroids formed equally fast in PCD patients and 
in healthy controls. The reported difference in median 
harvesting time was due to coincidence. If nasal brushing 
had been performed on a Thursday or Friday, the sphe-
roids would form during the following weekend, but not 
harvested until Monday.
Formation of 3D-E spheroids may be used as a much 
faster alternative to improve the diagnostic accuracy in 
diagnosing of PCD in cases where conventional work-up 
shows to be difficult. Our 3D-E spheroids showed valid 
ciliary function proven by CBP and CBF in at least 5 days 
in culture, and vital cilia proven by beating still after 
16 days. This makes it possible to re-analyze ciliary func-
tion from the same patient’s sample over an expanded 
time period if needed, in the same way as can be done 
by other in  vitro methods [7, 8]. We therefore believe 
that our 3D-E spheroid model may be useful for further 
understanding the pathophysiology of PCD and param-
eters of airway epithelium in general.
We further showed it feasible to characterize the 3D-E 
spheroids by IHC analysis. In line with previous obser-
vations [9–12], our analysis shows that the spheroids 
present well-organized arrangements of monolayer cells 
enclosing a partly fluid-filled lumen with the ciliated 
apical surface facing the outside. Further, IHC of the 
spheroids may come into hand for in-depth analyses of 
spheroids derived from healthy individuals versus PCD 
patients in relation to identification of axonemal aberra-
tions as well as defects in ciliary signaling systems that 
impact on ciliary beating.
In our 3D-E spheroid model, we used nasal cells from 
minimally invasive brush biopsies. This was different 
from the previous reported 3D-E model by Pedersen and 
co-workers [1, 9–12] and advantageous for us, since we 
did not need to rely on a patient having polyps for get-
ting material and since we could skip all enzymatic steps 
otherwise needed to release the epithelial cells from the 
underlying polyp tissue. The yield of spheroids was less 
from a brush biopsy compared to the yield from a whole 
nasal polyp.
Limitations of the study
Our study was small and among only eight cases of suc-
cessful PCD spheroids, we had four different types of 
dysmotility. More samples would be required in future 
studies to prove that our method is able to consistently 
replicate all dysmotilities among PCD patients.
In many cases, but not always, healthy cells formed 
rotating spheroids. Again, due to limited number of sam-
ples, a consistent pattern was difficult to find. It seemed 
that healthy cells aggregating in large spheroids were 
more prone to form rotating spheroids, since we exclu-
sively saw large rotating spheroids. In future, larger stud-
ies will be needed to further describe this phenomenon 
as well as more detailed quantitative and qualitative anal-
yses of the spheroid cilia.
With time, the spheroid cells will die. Day-to-day 
assessment of the fraction of living and dead ciliated cells 
in the spheroids was not performed in this study. How-
ever, the spheroids were harvested after only a few days 
(1–5 days) and CBF as well as CBP was unchanged, when 
comparing spheroid CBF and CBP to the initial cCFA 
CBF and CBP assessments. Thus suggesting that the 
overall ciliary functionality was preserved in the sphe-
roids at the time they were harvested.
We only assessed CBP and CBF by high-speed analy-
sis at a maximal spheroid age of 5 days in culture. A sin-
gle batch was kept with live and beating cilia for 16 days. 
Further studies are needed to determine for exactly how 
long the 3D-E spheroid cells maintain their initial ciliary 
functionality, when produced by the presented method. 
In a previous study of 3D-E spheroids produced from 
lung tissue and nasal polyps, the spheroids were kept via-
ble for 6 weeks when derived from lung tissue and up to 
6 months when derived from nasal polyps [20].
PCD patients are chronically infected in the nose. By 
adding antibiotics (penicillin/streptomycin) to the cell 
medium, the risk of losing spheroids due to infection is 
presumably less. Still, we lost 3/11 PCD samples to infec-
tion, compared to no spheroid infections in our healthy 
group. However, our overall success rate of 82% was still 
superior to previous reports (54–79%) [6, 19].
Spheroid CBP and CBF assessment required immobili-
zation of the spheroids.
Examining free moving spheroids without destroying 
their form would allow better options for further assess-
ing movements of these spheroids, including those spin-
ning around their own axis (example shown in Additional 
file 1). However, at this point we do not have a solution 
for this challenge.
Conclusion
We have shown three-dimensional explant (3D-E) sphe-
roid formation from patient-specific minimal inva-
sive nasal brush biopsy to be an extremely fast and easy 
ex vivo method for investigating ciliary function in airway 
epithelium, including a potential for assisting the diagno-
sis of PCD and with further potential for investigating 
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pathophysiological aspects of ciliated epithelium and of 
PCD.
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